Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery

NCT04420689 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Parotid Neoplasm
Thyroid Neoplasms
Head and Neck Neoplasms
Surgery
Nerve Injury
Imaging

Interventions

DRUG: Bevonescein

Sponsor

Alume Biosciences, Inc.